(Q46171924)

20 December 2017

title

Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. (English)

1 reference

20 December 2017

author name string

Morris Nechama

1

1 reference

20 December 2017

Iddo Z Ben-Dov

2

1 reference

20 December 2017

Justin Silver

3

1 reference

20 December 2017

Tally Naveh-Many

4

1 reference

20 December 2017

publication date

7 January 2009

1 reference

20 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

20 December 2017

volume

296

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

F795-800

1 reference

20 December 2017

Lanthanum carbonate: a new phosphate binder

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

The parathyroid is a target organ for FGF23 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

AU binding proteins recruit the exosome to degrade ARE-containing mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Environmental-dependent acceleration of a developmental switch: the floral transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Parathyroid hormone gene expression in hypophosphatemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Parathyroid growth and suppression in renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Regulation of parathyroid hormone mRNA stability by calcium, phosphate and uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90625.2008

10.1152/AJPRENAL.90625.2008

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19129257

1 reference

20 December 2017